• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BASP1 下调 RANKL 诱导的破骨细胞生成。

BASP1 down-regulates RANKL-induced osteoclastogenesis.

机构信息

Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot, 76100, Israel.

School of Cellular & Molecular Medicine, University of Bristol, Bristol, BS8 1TD, United Kingdom.

出版信息

Exp Cell Res. 2023 Oct 1;431(1):113758. doi: 10.1016/j.yexcr.2023.113758. Epub 2023 Aug 22.

DOI:10.1016/j.yexcr.2023.113758
PMID:37619639
Abstract

The cytokine RANKL (Receptor Activator of NFκB Ligand) is the key driver of differentiation of monocytes/macrophages to form multi-nucleated, bone-resorbing osteoclasts, a process that is accompanied by significant changes in gene expression. We show that exposure to RANKL rapidly down-regulates expression of Brain Acid Soluble Protein 1 (BASP1) in cultured primary mouse bone marrow macrophages (BMMs), and that this reduced expression is causally linked to the osteoclastogenic process in vitro. Knocking down BASP1 expression in BMMs or eliminating its expression in these cells or in RAW 264.7 cells enhanced RANKL-induced osteoclastogenesis, promoted cell-cell fusion, and generated cultures containing larger osteoclasts with increased mineral degrading abilities relative to controls. Expression of exogenous BASP1 in BMMs undergoing osteoclastogenic differentiation produced the opposite effects. Upon exposure to RANKL, primary mouse BMMs in which BASP1 had been knocked down exhibited increased expression of the key osteoclastogenic transcription factor Nfatc1and of its downstream target genes Dc-stamp, Ctsk, Itgb3, and Mmp9 relative to controls. The knock-down cells also exhibited increased sensitivity to the pro-osteoclastogenic effects of RANKL. We conclude that BASP1 is a negative regulator of RANKL-induced osteoclastogenesis, which down-regulates the pro-osteoclastogenic gene expression pattern induced by this cytokine. Decreased expression of BASP1 upon exposure of BMMs to RANKL removes a negative regulator of osteoclastogenesis and promotes this process.

摘要

细胞因子 RANKL(核因子 κB 配体受体激活剂)是单核细胞/巨噬细胞分化为形成多核、骨吸收破骨细胞的关键驱动因素,这一过程伴随着基因表达的显著变化。我们表明,暴露于 RANKL 可迅速下调培养的原代小鼠骨髓巨噬细胞(BMM)中 Brain Acid Soluble Protein 1(BASP1)的表达,并且这种表达减少与体外破骨细胞生成过程有关。在 BMM 中敲低 BASP1 表达或消除其在这些细胞或 RAW 264.7 细胞中的表达增强了 RANKL 诱导的破骨细胞生成,促进了细胞融合,并产生了含有更大破骨细胞的培养物,与对照相比,其具有增加的矿物质降解能力。在经历破骨细胞生成分化的 BMM 中表达外源性 BASP1 产生了相反的效果。暴露于 RANKL 后,与对照相比,BASP1 被敲低的原代小鼠 BMM 中关键破骨细胞生成转录因子 Nfatc1 的表达及其下游靶基因 Dc-stamp、Ctsk、Itgb3 和 Mmp9 的表达增加。敲低细胞对 RANKL 的促破骨细胞生成作用也表现出更高的敏感性。我们得出结论,BASP1 是 RANKL 诱导的破骨细胞生成的负调节剂,它下调了该细胞因子诱导的促破骨细胞生成基因表达模式。BMM 暴露于 RANKL 时 BASP1 的表达减少去除了破骨细胞生成的负调节剂,并促进了这一过程。

相似文献

1
BASP1 down-regulates RANKL-induced osteoclastogenesis.BASP1 下调 RANKL 诱导的破骨细胞生成。
Exp Cell Res. 2023 Oct 1;431(1):113758. doi: 10.1016/j.yexcr.2023.113758. Epub 2023 Aug 22.
2
Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.新藤黄酸通过抑制小鼠骨髓来源的单核/巨噬细胞中的 JNK 和 NF-κB 通路抑制核因子 κB 受体激活剂配体 (RANKL)诱导的破骨细胞生成。
Med Sci Monit. 2018 Apr 26;24:2569-2577. doi: 10.12659/MSM.909651.
3
Estrogen-related receptor γ negatively regulates osteoclastogenesis and protects against inflammatory bone loss.雌激素相关受体 γ 负向调节破骨细胞生成并防止炎症性骨丢失。
J Cell Physiol. 2019 Feb;234(2):1659-1670. doi: 10.1002/jcp.27035. Epub 2018 Aug 4.
4
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.新型NF-κB抑制剂(-)-DHMEQ通过下调NFATc1抑制RANKL诱导的破骨细胞生成。
J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6.
5
Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.微管肌动蛋白交联因子 1(MACF1)敲低通过 Akt/GSK3β/NFATc1 信号通路抑制 RANKL 诱导的破骨细胞生成。
Mol Cell Endocrinol. 2019 Aug 20;494:110494. doi: 10.1016/j.mce.2019.110494. Epub 2019 Jun 28.
6
RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.RGS18通过调节酸敏感OGR1/NFAT信号通路,作为破骨细胞生成的负调节因子。
J Bone Miner Res. 2007 Oct;22(10):1612-20. doi: 10.1359/jbmr.070612.
7
FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.FTY720抑制伴放线聚集杆菌诱导的促炎细胞因子释放和破骨细胞生成。
Lipids Health Dis. 2015 Jul 4;14:66. doi: 10.1186/s12944-015-0057-7.
8
Regulation of RANKL-induced osteoclastogenesis by RING finger protein RNF114.环状泛素连接酶RNF114对RANKL诱导的破骨细胞生成的调控
J Orthop Res. 2018 Jan;36(1):159-166. doi: 10.1002/jor.23654. Epub 2017 Jul 31.
9
CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.CTRP3在体外通过AMPK-c-Fos-NFATc1信号传导充当破骨细胞生成的负调节因子,并在体内抑制RANKL诱导的颅骨骨破坏。
Bone. 2015 Oct;79:242-51. doi: 10.1016/j.bone.2015.06.011. Epub 2015 Jun 21.
10
Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.刺参素D通过下调c-Fos、NFATc1和NF-κB抑制RANKL诱导的破骨细胞生成。
Mar Drugs. 2014 Nov 24;12(11):5643-56. doi: 10.3390/md12115643.

引用本文的文献

1
TMT-based quantitative proteomic analysis of IBDV-infected CEF cells reveals a favorable role of chicken IRF10 in IBDV replication via suppressing type-I interferon expression.基于TMT的传染性法氏囊病病毒感染的鸡胚成纤维细胞定量蛋白质组学分析揭示了鸡干扰素调节因子10通过抑制I型干扰素表达在传染性法氏囊病病毒复制中发挥有利作用。
Poult Sci. 2024 Dec;103(12):104421. doi: 10.1016/j.psj.2024.104421. Epub 2024 Oct 13.
2
Osteophyte Cartilage as a Potential Source for Minced Cartilage Implantation: A Novel Approach for Articular Cartilage Repair in Osteoarthritis.骨赘软骨作为碎软骨植入的潜在来源:骨关节炎关节软骨修复的一种新方法。
Int J Mol Sci. 2024 May 20;25(10):5563. doi: 10.3390/ijms25105563.